Please login to the form below

Not currently logged in


This page shows the latest Entyvio news and features for those working in and with pharma, biotech and healthcare.

Modest meeting sees only two drugs recommended by CHMP

Modest meeting sees only two drugs recommended by CHMP

Takeda also picked up a positive recommendation for a new subcutaneous formulation of its ulcerative colitis and Crohn’s med Entyvio (vedolizumab).

Latest news

More from news
Approximately 8 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Millennium Pharmaceuticals for $8.8bn, when he was part of the team developing Entyvio. ... The buzz was that Entyvio wouldn’t make it and there were tremendous challenges, but the uniqueness of its mode of action kept us going.”.

  • Forging a path in specialty care Forging a path in specialty care

    Adcetris (for Hodgkin Lymphoma), Entyvio (for ulcerative colitis and Crohn's Disease) and future compound Ninlaro (an oral protease inhibitor for relapsed/refractory multiple myeloma) which was approved by the FDA ... The best example is Entyvio. It

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....